Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer-Reference-Cited by-同舟云学术

Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer

Published:2012-08-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Deva Sanjeev¹,Jameson Michael²

Affiliation:

1. Auckland Hospital; Cancer and Blood; Park Road Grafton Auckland New Zealand

2. Waikato Hospital; Oncology Department; Cnr Pembroke and Lorne Street Hamilton Waikato New Zealand

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007814.pub2/fullpdf

Reference51 articles.

1. Short-course cimetidine and survival with colorectal cancer;Adams;Lancet,1994

2. The effect of a short course of preoperative cimetidine in the grade of TIL in primary colorectal cancer - a randomised controlled clinical trial.;Finlay;GI cancer,1999

3. Cimetidine as adjuvant treatment in rectal cancer;Huang;Chinese journal of cancer prevention and treatment,2007

4. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.;Matsumoto;British Journal of Cancer,2002

5. Ranitidine as adjuvant treatment in colorectal cancer;Nielsen;British Journal of Surgery,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological role of histamine signaling and its implications in glioblastoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. H2 antihistamines: May be useful for combination therapies in cancer?;Biochemical Pharmacology;2024-05

3. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers;European Journal of Pharmacology;2023-12

4. The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy;Scientific Reports;2023-10-10

5. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01